May 13, 2025
This conference advances understanding of biological, genetic, social, and
environmental factors influencing equity in blood cancer treatment outcomes.
Topics include:
• Prognostic and therapeutic impact of germline and somatic variants
• The impact of social determinants of health on outcomes
• Increasing community representation in clinical trials
• Lymphoproliferative disorder burden in Latin America and lower middle income countries